Multimedia | NCATS

View of a cell under a microscope

Visit our collection of videos or browse our fact sheets and infographics to learn more about us and download them to share our resources and activities with others.

Videos

Watch our collection of videos to learn more about NCATS and get a behind-the-scenes look at our research activities.

Image displaying six of the video thumbnails from the NCATS YouTube video library.

Our videos feature informative interviews with NCATS leadership and staff, inspiring patient stories, virtual lab tours, helpful grantee resources and more.

Visit the NCATS YouTube Channel

NCATS Infographics & Fact Sheets

The first page of a fact sheet about 3-D tissue models with a banner image at the top followed by text.

3-D Tissue Models

NCATS designs and helps develop 3-D tissue models to help researchers better predict which promising treatments will move from the lab to success in clinical trials in people.

Read About 3-D Tissue Models

The first page of a fact sheet about rare diseases with a banner image at the top followed by text.

Assay Guidance Manual

The Assay Guidance Manual is a free, best-practices online resource devoted to the successful development of robust, early-stage drug discovery assays.

Read About AGM (PDF - 226KB)

A researcher types into the computer screen “predict treatments for disease y.” The query is sent to the Translator’s Autonomous Relay Agents (ARAs) to determine how best to answer the query. The ARA will then break the query into smaller tasks that are transmitted to rich, specialty knowledge bases called Knowledge Providers (KPs). This process will be iterative, such that the ARAs and KPs can build on information from the others. The last sequence is the results of the query showing up on the computer scr

Biomedical Data Translator

This program brings together teams of experts from leading universities and research institutions to combine vast amounts of current medical research data and speed the development of new treatments.

Learn More About Translator Projects

The first page of a fact sheet about rare diseases with a banner image at the top followed by text.

Core Technologies

NCATS uses state-of-the-art resources and core technologies to enable the ongoing operation of all translational research activities happening at the Center.

Read About Core Technologies (PDF - 250KB)

The first page of a fact sheet about rare diseases with a banner image at the top followed by text.

National Clinical Cohort Collaborative (N3C)

The National Clinical Cohort Collaborative (N3C) maintains one of the largest collections of secure and deidentified clinical data in the United States for COVID-19 research.

Read About N3C (PDF - 282KB)

 


 

First page of a factsheet

NCATS Drug Repurposing

Drug repurposing finds approved drugs and investigational compounds that might be able to treat other diseases and conditions. We use drug repurposing as a key strategy for bringing more treatments for all people more quickly.

Read About NCATS Drug Repurposing (PDF - 688KB)

The NCATS Pharmaceutical Collection (NPC) is a storehouse of approved drugs. Scientists use the collection to identify potential ways to repurpose drugs for new uses.

NCATS National Pharmaceutical Collection

The NCATS National Pharmaceutical Collection is a complete, publicly available collection of approved molecular parts for high-throughput screening. The collection provides a valuable resource for validating new models of disease and understanding the molecular basis of diseases and interventions better.

Learn More About the Pharmaceutical Collection (PDF - 451KB)

First page of a fact sheet

NCATS OpenData Portal

The OpenData Portal offers real-time information about how individual SARS-CoV-2 variants may respond to known therapeutics. It also focuses on NCATS’ broader drug repurposing findings and other pandemic threats.

Read About the OpenData Portal (PDF - 241KB)

Mission. Turn research observations into health solutions through translational science. Vision. Bring more treatments for all people more quickly. Goal 1. Advance development of and access to more treatments, particularly for diseases with unmet needs. Goal 2. Empower everyone to contribute to and benefit from translational science. Goal 3. Accelerate translational science by breaking barriers and boosting efficiency. Goal 4. Leverage crosscutting strategies to enhance translational science. Goal 5. Champi

NCATS Strategic Plan Framework

The Strategic Plan Framework includes 5 goals with supporting objectives to bring more treatments for all people more quickly.

View the NCATS Strategic Plan Framework (PDF - 1.22 MB)

First page of a factsheet

Rare Diseases

NCATS supports a range of innovative approaches for understanding and treating rare diseases, which affect millions of people in this country.

Read About Rare Diseases (PDF - 350KB)

A graphic image that has stylized depictions of facts and statistics from the publication, The IDeaS Initiative: Pilot Study to Assess the Impact of Rare Diseases on Patients and Healthcare Systems.

Rare Diseases Overview

NCATS is developing new approaches to diagnose and treat people with rare diseases more quickly.

View the Rare Diseases Infographic (PDF - 110.14 KB)

Factsheet

Small Business Innovation

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs engage U.S. small businesses and research organizations in research and development that has the potential for commercialization and public benefit.

Read About SBIR/STTR Programs (PDF - 250KB)

Picture of person called “chip” with 13 clickable icons representing tissues and organ systems they represent, 2 icons are not clickable. The clickable icons are: brain; lungs, heart, muscle, liver, kidneys, gastrointestinal system, female reproductive system, blood vessels, fat, joints, skin and disease models. The two unclickable icons represent the ear and male reproductive system.

Tissue Chips for Drug Screening

Developing new treatments for patients is a long and hard process. Often tests conducted in the early stages of research do not accurately predict how well a treatment will work or if it will cause any harm to humans. This leads to long delays and enormous costs while patients eagerly await effective treatments. The Tissue Chip for Drug Screening program at NCATS brings innovation to the table. By using specialized chips, this program is making exciting advancements in drug testing.

Learn More About Tissue Chips

 

Copyright and Reuse of Graphics

The NCATS website uses a mix of copyrighted and copyright-free graphics (including illustrations and photos). If you want to reuse a graphic, please follow these guidelines:

  • Copyrighted graphics will usually be credited to individuals or organizations. Permission to reuse these must be negotiated directly with the creators, and not NCATS.
  • Graphics explicitly credited to NCATS are copyright-free and may be used without our permission. Please credit the National Center for Advancing Translational Sciences as the source.

If you are not sure who created a graphic or have other questions about reusing a graphic on the NCATS website, email NCATS at ncatsinfo@nih.gov . Please include the URL and file name in your email.